CONFERENCES

    International Society for Biological and Environmental Repositories

    ISBER is an annual conference that focuses on the use of biobanks, with topics ranging from biobank education to technological innovation. The conference is aimed at researchers, biobank managers, and other professionals involved in the collection, storage, and use of biological specimens, and provides a forum for the dissemination of state-of-the-art policies, processes, and research findings

    ISBER VIRTUAL Annual Meeting and Exhibits 2020

    Date

    Apr 14, 2020 - Apr 18, 2020

    Location

    Online

    In April 2020, global leaders and disruptors from the broad spectrum of scientific community will converge in the largest international biobank conference, ISBER 2020, to address the impact of biobanks on science and how the related discoveries are establishing a roadmap to extend our knowledge network.

    ISBER Annual Meeting and Exhibits 2018

    Date

    May 20, 2018 - May 24, 2018

    Location

    Dallas, USA

    The theme of the annual meeting this year is: "Seizing BIG Opportunities in Biobanking Through Data, Collaboration, and Innovation".

    See related posters

    PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
    ​
    Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.